An exciting opportunity awaits you within the Patient Focused Real World Evidence (PRWE) Team for Oncology (Early Phase Development). As passionate leaders of patient focused real world data, evidence generation, and epidemiology, we are uniquely placed to enable fit-for-purpose visionary solutions. Our team operates with a proactive and agile approach, as a trusted partner in qualitative and quantitative sciences, all while striving towards the common goal to deliver more medicines to more patients faster. As a key member of our team, you will drive the Real-World Evidence and Data (RWE/D) strategy and studies, with a particular focus on early drug development and integrated evidence planning. You will provide scientific leadership and expertise to ensure that fit-for-purpose RWD are integrated in evidence generation plans and available to support program´s decision-marking and regulatory submissions. You will lead the design, implementation and oversight of disease or drug-specific RWE studies, encompassing regulatory grade studies, i.e. safety related studies, external control arm studies and natural history of disease studies. Your work will involve inspiring cross-functional collaboration, in a unique partnership with other quantitative scientists while also maintaining and expanding our external collaborations. Who you are:Background in health and life sciences (epidemiology, public health, MD, pharm D), or quantitative data sciences, biostatisticsDoctoral and/or master’s degree (e.g., PhD, MSc) in Epidemiology, Public Health or related fieldStrong experience in RWE/D within the pharmaceutical industry, particularly in the application of RWE in drug development for rare indications and early phase developmentPrior experience in supporting the therapeutic area of OncologyDemonstrable experience in leading RWE generation plans and studies end-to end, including application of innovative designs and methodsExcellent oral and written communication skills and demonstrated ability to engage and communicate scientific evidence to peers and at scientific meetingsCollaborative, proactive working style, with ability to work independently.